1. Genes (Basel). 2019 Aug 22;10(9):633. doi: 10.3390/genes10090633.

One NF1 Mutation may Conceal Another.

Pacot L(1)(2), Burin des Roziers C(1)(2), Laurendeau I(2), Briand-Suleau 
A(1)(2), Coustier A(1), Mayard T(1), Tlemsani C(1)(2), Faivre L(3)(4), Thomas 
Q(3)(4), Rodriguez D(5)(6), Blesson S(7), Dollfus H(8)(9)(10), Muller YG(9), 
Parfait B(1)(2), Vidaud M(1)(2), Gilbert-Dussardier B(11), Yardin C(12)(13), 
Dauriat B(12), Derancourt C(14)(15), Vidaud D(1)(2), Pasmant E(16)(17).

Author information:
(1)Service de Génétique et Biologie Moléculaires, Hôpital Cochin, HUPC, 
Assistance Publique-Hôpitaux de Paris, 75014 Paris, France.
(2)Institut Cochin, INSERM U1016, Université Paris Descartes, 75014 Paris, 
France.
(3)Inserm, UMR 1231, Génétique des Anomalies du Développement, Université de 
Bourgogne, 21079 Dijon, France.
(4)Centre de Référence Anomalies du Développement et Syndromes Malformatifs, 
Hôpital d'Enfants, 21079 Dijon, France.
(5)Department of Child Neurology and National Reference Center for Neurogenetic 
Disorders, Armand Trousseau Hospital, GHUEP, AP-HP, INSERM U1141, 75012 Paris, 
France.
(6)GRC n°19 ConCer-LD, Sorbonne Université, 75012 Paris, France.
(7)Service de Génétique, CHRU de Tours, 37044 Tours, France.
(8)Centre de référence pour les Affections Rares en Génétique Ophtalmologique 
(CARGO), Hôpital Civil, 67091 Strasbourg, France.
(9)Service de Génétique Médicale, Hôpital de Hautepierre, 67200 Strasbourg, 
France.
(10)Laboratoire de Génétique Médicale, INSERM U1112, 67000 Strasbourg, France.
(11)Service de Génétique, EA3808, Université de Poitiers, CHU de Poitiers, 86000 
Poitiers, France.
(12)Department of Cytogenetics and clinical genetics, Limoges University 
Hospital, 87042 Limoges, France.
(13)UMR 7252, Limoges University, CNRS, XLIM, 87000 Limoges, France.
(14)EA 4537, Antilles University, 97261 Fort-de-France, Martinique, France.
(15)DRCI, Martinique University Hospital, 97261 Fort-de-France, Martinique, 
France.
(16)Service de Génétique et Biologie Moléculaires, Hôpital Cochin, HUPC, 
Assistance Publique-Hôpitaux de Paris, 75014 Paris, France. 
eric.pasmant@parisdescartes.fr.
(17)Institut Cochin, INSERM U1016, Université Paris Descartes, 75014 Paris, 
France. eric.pasmant@parisdescartes.fr.

Neurofibromatosis type 1 (NF1) is an autosomal dominant disease with complete 
penetrance but high variable expressivity. NF1 is caused by loss-of-function 
mutations in the NF1 gene, a negative regulator of the RAS-MAPK pathway. The NF1 
gene has one of the highest mutation rates in human disorders, which may explain 
the outbreak of independent de novo variants in the same family. Here, we report 
the co-occurrence of pathogenic variants in the NF1 and SPRED1 genes in six 
families with NF1 and Legius syndrome, using next-generation sequencing. In five 
of these families, we observed the co-occurrence of two independent NF1 
variants. All NF1 variants were classified as pathogenic, according to the 
American College of Medical Genetics and Genomics and the Association for 
Molecular Pathology (ACMG-AMP) guidelines. In the sixth family, one sibling 
inherited a complete deletion of the NF1 gene from her mother and carried a 
variant of unknown significance in the SPRED1 gene. This variant was also 
present in her brother, who was diagnosed with Legius syndrome, a differential 
diagnosis of NF1. This work illustrates the complexity of molecular diagnosis in 
a not-so-rare genetic disease.

DOI: 10.3390/genes10090633
PMCID: PMC6769760
PMID: 31443423 [Indexed for MEDLINE]

Conflict of interest statement: The authors declare no conflict of interest.